Dick Pluim

5.4k citations
74 papers · 4.6k · 2 hit papers · h-index 33

Impact in

  • Oncology top 1%
    • Metal complexes synthesis and properties
    • Drug Transport and Resistance Mechanisms
    • Nanoparticle-Based Drug Delivery

Papers in

    • Drug Transport and Resistance Mechanisms 15
    • Colorectal Cancer Treatments and Studies 11
    • Cancer Immunotherapy and Biomarkers 7
    • Pharmacogenetics and Drug Metabolism 8

Dick Pluim

73 papers receiving 4.5k citations

Dick Pluim's Hit Papers

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 2014 · 338 citations
3380+7+14Years since publication250500750

Peers

Dick Pluim
Comparison fields: 5 of 117
  • Oncology 2.8k
  • Biomaterials 452
  • Organic Chemistry 918
  • Molecular Biology 1.6k
  • Pediatrics, Perinatology and Child Health 375
Replace Pranav Gupta with:
Pranav Gupta United States
Klaus B. Mross Germany
Dong‐Hua Yang United States
Catherine L. Booth-Genthe United States
Walter J. Loos Netherlands
Pierantonio Menna Italy
Renzo M. Canetta United States
Emanuela Salvatorelli Italy
Kenneth R. Harrap United Kingdom
Peter Charlton United Kingdom
Dick Pluim relative to Pranav Gupta United States Pranav Gupta's profile →
Citations per field
00.5×1.5×2×2.3×
Pranav Gupta · 1×
Citations per year

Countries citing papers authored by Dick Pluim

Since Specialization
Citations

This map shows the geographic impact of Dick Pluim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick Pluim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick Pluim more than expected).

Fields of papers citing papers by Dick Pluim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick Pluim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick Pluim. The network helps show where Dick Pluim may publish in the future.

Co-authors

The 25 scholars most cited alongside Dick Pluim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dick Pluim Line = papers co-authored together Dick Pluim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
Hit paper breakdown →
2004784
2
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
1999427
3
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Hit paper breakdown →
2014338
4 2005296
5 2016271
6 2004203
7
Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.
2001202
8 2004186
9 2004146
10 2002105
11 200689
12 200882
13 200481
14 200280
15 201774
16 201865
17 201563
18 200859
19 202056
20 199552

About Dick Pluim

Dick Pluim is a scholar working on Oncology, Pharmacology, Molecular Biology, Genetics and Cancer Research, having authored 74 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Cancer therapeutics and mechanisms (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Pharmacogenetics and Drug Metabolism (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Biochemical and Molecular Research (4 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Oncology (2.8k citations), Biomaterials (452 citations), Organic Chemistry (918 citations), Molecular Biology (1.6k citations) and Pediatrics, Perinatology and Child Health (375 citations). Dick Pluim has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Jan H.M. Schellens, Jos Beijnen, Jeany M. Rademaker-Lakhai, Desirée H J G van den Bongard, Marc Maliepaard, Olaf van Tellingen, Robert C.A.M. van Waardenburg, Pauline Breedveld, Matthijs M. Tibben and Alfred H. Schinkel. Their work appears in journals such as Clinical Cancer Research, Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology, Investigational New Drugs and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact